Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL905508 | 0.84 | KIF11 (0.36) | TSHRLMNATYRALDH1A1KIF11 | |
| SCHEMBL956938 | 0.75 | TSHR (0.40) | TSHRTDP1ACHE | |
| SCHEMBL1550638 | 0.75 | TSHR (0.46) | TSHRLMNATYRALDH1A1HPGD | |
| SCHEMBL25227526 | 0.73 | POLB (0.39) | TSHRLMNATYRALDH1A1HPGD | |
| SCHEMBL1639237 | 0.73 | LMNA (0.48) | TSHRLMNATYRALDH1A1HPGD | |
| SCHEMBL16166891 | 0.73 | ACHE (0.31) | ACHE | |
| SCHEMBL6225432 | 0.73 | TSHR (0.39) | TSHRLMNATYRALDH1A1HPGD | |
| SCHEMBL17262489 | 0.73 | TSHR (0.39) | TSHRLMNATYRALDH1A1HPGD | |
| SCHEMBL7044344 | 0.73 | CYP2A6 (0.32) | ALDH1A1 | |
| SCHEMBL11798351 | 0.73 | TSHR (0.39) | TSHRLMNATYRALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117983302-A | Catalyst containing ferrocene PNP ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-115010839-B | Amine-containing bisphenol tetradentate ligand fourth subgroup metal complex catalyst system and application thereof | 吉林大学 | 2023-06-20 | — | — | CN | claimed |
| CN-114716585-B | Catalyst system containing aryloxy side-arm metallocene fourth subgroup metal complex and application thereof | 吉林大学 | 2023-02-28 | — | — | CN | claimed |
| CN-112830989-B | Long-chain branched ethylene propylene rubber and preparation method thereof | 北京引发科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| US-11150555-B2 | Photoacid generator and chemically amplified positive-type photoresist composition for thick film comprising the same | LG CHEM, LTD. (KR) | 2021-10-19 | — | — | US | claimed |
| CN-112830989-A | Long-chain branched ethylene propylene rubber and preparation method thereof | 北京引发科技有限公司 | 2021-05-25 | — | — | CN | claimed |
| US-20200033724-A1 | PHOTOACID GENERATOR AND CHEMICALLY AMPLIFIED POSITIVE-TYPE PHOTORESIST COMPOSITION FOR THICK FILM COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-01-30 | — | — | US | claimed |
| US-20190161514-A1 | AZASTEROIDS FOR TREATMENT OF TUBERCULOSIS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2019-05-30 | — | — | US | claimed |
| CN-109790200-A | For treating the azasteroid of tuberculosis | 纽约州立大学研究基金会 | 2019-05-21 | — | — | CN | claimed |
| US-9932423-B2 | Hydrogenation of annulated cyclopentadienyl metal complexes and metallocene catalysts comprising such | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-04-03 | — | — | US | claimed |
| EP-0805826-A2 | ALPHA-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| US-5650513-A | Process for preparing perylene-3,4-dicarboxylic acid derivatives, the derivatives thus prepared and their use | CIBA-GEIGY CORPORATION (US) | 1997-07-22 | — | — | US | claimed |
| EP-0596553-B1 | Catalyst composition for alkene oligomerisation and co-oligomerisation | SHELL INT RESEARCH (NL) | 1997-05-07 | — | — | EP | claimed |
| WO-1996023010-A2 | α-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-08-01 | — | — | WO | claimed |
| EP-0711812-A1 | Method of preparation of perylene imides, novel di-, tri-, and tetrachromophore perylene dyestuffs and their utilization | CIBA-GEIGY AG (CH) | 1996-05-15 | — | — | EP | claimed |
| US-5508137-A | REACTING A PERYLENE-3,4:9,10-TETRACARBOXYLIC MONOANHYDRIDE MONOIMIDE WITH A PRIMARY DIAMINE; FLUORESCENT DYE IN CHEMILUMINESCENCE SYSTEMS | CIBA-GEIGY CORPORATION (US) | 1996-04-16 | — | — | US | claimed |
| EP-0657436-A2 | Process for the preparation of perylene-3,4-dicarboxylic acid derivatives, the compounds prepared according to this process and their use | CIBA-GEIGY AG (CH) | 1995-06-14 | — | — | EP | claimed |
| EP-0638613-A1 | Perylene amidine-imide dyes, a process for their production and their use | CIBA-GEIGY AG (CH) | 1995-02-15 | — | — | EP | claimed |
| EP-0596553-A2 | Catalyst composition for alkene oligomerisation and co-oligomerisation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1994-05-11 | — | — | EP | claimed |
| US-4845223-A | FLUORESCENT PERYLENE DYES | BASF AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200033724-A1 | PHOTOACID GENERATOR AND CHEMICALLY AMPLIFIED POSITIVE-TYPE PHOTORESIST COMPOSITION FOR THICK FILM COMPRISING THE SAME | ASIC1, PPA1, ATP6AP1 | TSHR 3936/4885LMNA 4181/4885TYR 387/4885 |
| US-20190161514-A1 | AZASTEROIDS FOR TREATMENT OF TUBERCULOSIS | CYP51A1, HSD17B13, HSD17B1 | TSHR 914/4885LMNA 2730/4885TYR 4727/4885 |
| US-11150555-B2 | Photoacid generator and chemically amplified positive-type photoresist composition for thick film comprising the same | ASIC1, PPA1, ATP6AP1 | TSHR 3936/4885LMNA 4181/4885TYR 387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.